Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of TGF-beta as a Potential Target for Prevention of Radiation-Induced Injury

NCT00897793 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT00897793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00897793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of TGF-beta as a Potential Target for Prevention of Radiation-Induced Injury
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Observational
Overall status
Completed
Start date
January 31, 2006
Completion date
July 31, 2010
Enrollment
25 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal cancer, head and neck cancer, lung cancer, prostate cancer